IRIS
ATZENI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.221
EU - Europa 2.227
AS - Asia 836
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 7.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.211
IE - Irlanda 1.242
CN - Cina 732
SE - Svezia 632
IT - Italia 200
PL - Polonia 68
IN - India 66
BE - Belgio 19
DE - Germania 14
VN - Vietnam 14
CA - Canada 10
BR - Brasile 8
FR - Francia 8
GB - Regno Unito 8
FI - Finlandia 7
IR - Iran 7
NL - Olanda 7
EU - Europa 6
UA - Ucraina 6
CH - Svizzera 4
ES - Italia 4
IQ - Iraq 4
PT - Portogallo 3
AU - Australia 2
CO - Colombia 2
DK - Danimarca 2
KZ - Kazakistan 2
QA - Qatar 2
SA - Arabia Saudita 2
TR - Turchia 2
AT - Austria 1
BD - Bangladesh 1
GR - Grecia 1
HK - Hong Kong 1
RO - Romania 1
SG - Singapore 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.302
Salva come PNG Salva come JPEG
Città #
Dublin 1.240
Chandler 1.010
Nyköping 462
Beijing 414
New York 291
Princeton 271
Jacksonville 248
Dearborn 245
Medford 228
Des Moines 199
Cambridge 167
Ashburn 108
Ann Arbor 74
Warsaw 68
Pune 58
Wilmington 58
Messina 53
Nanjing 42
Shenyang 40
Jinan 33
Boardman 22
Falls Church 21
Brussels 19
San Mateo 19
Haikou 18
Hebei 18
Los Angeles 18
Ningbo 18
Catania 17
Guangzhou 16
Zhengzhou 16
Norwalk 15
Dong Ket 14
Hangzhou 14
Nanchang 14
Seattle 14
Tianjin 14
Fuzhou 10
Leawood 10
Jiaxing 9
Changsha 8
Taizhou 8
Caltagirone 7
Piazza Armerina 7
Redwood City 7
Washington 7
Hefei 6
Rome 6
Ardabil 5
Cagliari 5
Florence 5
Lanzhou 5
Milan 5
Monmouth Junction 5
San Lorenzo del Vallo 5
Taiyuan 5
Bremen 4
Houston 4
Paris 4
Amsterdam 3
Augusta 3
Chengdu 3
Erbil 3
Gioiosa Marea 3
Iowa City 3
Itu 3
London 3
Milwaukee 3
Mountain View 3
Padova 3
Porto 3
Woodbridge 3
Almaty 2
Bello 2
Changle 2
Davis 2
Fairfield 2
Lyon 2
Naples 2
Ottawa 2
Palermo 2
Siena 2
Tappahannock 2
Treviso 2
Turin 2
Urbino 2
Varennes 2
Ancaster 1
Athens 1
Baghdad 1
Baotou 1
Bari 1
Bengaluru 1
Birmingham 1
Borca 1
Brescia 1
Brooklyn 1
Canicattì 1
Capoterra 1
Chaoyang 1
Totale 5.815
Salva come PNG Salva come JPEG
Nome #
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 73
Algo-dysfunctional syndromes: a critical digest of the recent literature 66
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 64
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria? 55
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 55
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 54
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 53
Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register 52
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 52
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 51
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 51
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 51
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis 50
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same? 50
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 48
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 48
B Lymphocyte intestinal homing in inflammatory bowel disease 47
Biomarkers in Rheumatoid Arthritis 47
Immunogenicity and autoimmunity during anti-TNF therapy 47
Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound 46
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry 45
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 45
Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: An assessment of combined tests 45
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 44
Web/Internet-based telemonitoring of a randomized controlled trial evaluating the time-integrated effects of a 24-week multicomponent intervention on key health outcomes in patients with fibromyalgia 44
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 44
Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients 43
Chronic widespread pain in the spectrum of rheumatological diseases 43
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 43
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 43
Autoantibody profile during short-term infliximab treatment for Crohn's disease: A prospective cohort study 42
Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases 42
From autoinflammation to autoimmunity: old and recent findings 42
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 42
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 42
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update 41
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: Results of an italian multicentre study 41
null 41
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 41
AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS) 41
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies? 41
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 41
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 41
Predicting response to anti-TNF treatment in rheumatoid arthritis patients 41
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis 40
Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjögren's syndrome? 40
Autoimmune hepatitis and allergic reactions during anti-TNFα treatment 40
One year in review 2019: fibromyalgia 40
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 40
Systemic rheumatic diseases: from biological agents to small molecules 40
EULAR recommendations for management of fibromyalgia 40
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 39
Measurement of Serum Klotho in Systemic Sclerosis 39
EULAR revised recommendations for the management of fibromyalgia 39
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 39
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 39
Cardiovascular involvement in systemic autoimmune diseases 38
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 38
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value 38
Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease 38
A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data 38
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 38
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis 38
Impaired lung transfer factor in fibromyalgia syndrome 38
Psoriatic arthritis registries 38
Safety of Abatacept in Rheumatoid Arthritis with Serologic Evidence of Past or Present Hepatitis B Virus Infection 37
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: A one-year prospective study 37
CC chemokine receptor 5 polymorphism in Italian patients with Beḩet's disease 37
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 37
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 37
Clinical comparison of QUANTA flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies 36
Pain in systemic connective tissue diseases 36
Rheumatic diseases and autoimmune vascular dementia 36
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease 36
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome 36
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients 36
Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography 36
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sjögren’s Project Consortium 36
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis: A retrospective multicenter Italian study 35
Features of mood associated with high body weight in females with fibromyalgia 35
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 35
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 35
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 35
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort 35
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 35
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents 35
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 35
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry 34
null 34
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: Real-life data from the LORHEN registry 34
Costs associated with rheumatoid arthritis in Italy: past, present, and future 34
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 34
A possible link between ankylosing spondylitis and periodontitis: A systematic review and meta-analysis 34
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 34
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project) 34
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 34
Measuring psoriatic disease in clinical practice. An expert opinion position paper 33
Cardiovascular and autoimmune diseases in females: The role of microvasculature and dysfunctional endothelium 33
Infections and Biological Therapy in Patients with Rheumatic Diseases 33
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 33
Totale 4.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020994 2 1 0 9 13 190 188 63 91 188 214 35
2020/2021836 10 16 183 23 272 13 51 97 59 47 48 17
2021/20221.185 9 60 4 30 97 21 28 51 36 55 170 624
2022/20233.463 313 223 155 315 169 350 21 199 1.567 14 110 27
2023/20241.033 94 134 194 83 69 388 7 33 4 27 0 0
Totale 7.891